499 related articles for article (PubMed ID: 30334462)
1. Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis.
Zheng Q; Chen ZX; Xu MB; Zhou XL; Huang YY; Zheng GQ; Wang Y
Drug Deliv; 2018 Nov; 25(1):1617-1633. PubMed ID: 30334462
[TBL] [Abstract][Full Text] [Related]
2. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.
Zhang QL; Fu BM; Zhang ZJ
Drug Deliv; 2017 Nov; 24(1):1037-1044. PubMed ID: 28687052
[TBL] [Abstract][Full Text] [Related]
3. [Effect of electroacupuncture combined with intragastric administration of borneol on the permeability of blood-brain barrier in the mouse].
Yu B; Lü GH; Sun Y; Lin X; Fang TH
Zhen Ci Yan Jiu; 2011 Oct; 36(5):335-40. PubMed ID: 22073884
[TBL] [Abstract][Full Text] [Related]
4. Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism.
Chen ZX; Xu QQ; Shan CS; Shi YH; Wang Y; Chang RC; Zheng GQ
Oxid Med Cell Longev; 2019; 2019():2936737. PubMed ID: 30863478
[TBL] [Abstract][Full Text] [Related]
5. Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors.
Wu JY; Li YJ; Yang L; Hu YY; Hu XB; Tang TT; Wang JM; Liu XY; Xiang DX
Drug Deliv; 2018 Nov; 25(1):1858-1864. PubMed ID: 30338713
[TBL] [Abstract][Full Text] [Related]
6. [Effect factors and mechanisms of borneol's bidirectional regulation on blood-brain barrier permeability].
Wang HJ; Wu JJ; Xue Q; Zhang JF; Xu XY
Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(11):2200-2207. PubMed ID: 28822169
[TBL] [Abstract][Full Text] [Related]
7. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
Banks WA
Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study.
Yu B; Ruan M; Dong X; Yu Y; Cheng H
J Ethnopharmacol; 2013 Dec; 150(3):1096-108. PubMed ID: 24432371
[TBL] [Abstract][Full Text] [Related]
9. L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin.
Yin Y; Cao L; Ge H; Duanmu W; Tan L; Yuan J; Tunan C; Li F; Hu R; Gao F; Feng H
Neuroreport; 2017 Jun; 28(9):506-513. PubMed ID: 28471848
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of vitamin E-TPGS and guar gum to carry borneol for enhancing blood-brain barrier permeability.
Liu Y; Rao L; Zhang H; Cen Y; Cheng K
J Biomater Appl; 2018 Oct; 33(4):590-598. PubMed ID: 30208770
[TBL] [Abstract][Full Text] [Related]
11. [Borneol promotes oral absorption and penetration into brain of puerarin and catalpol].
Tang DD; Zhang J; Wang JR; Zhang JF; Xu XY
Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2720-2726. PubMed ID: 28905612
[TBL] [Abstract][Full Text] [Related]
12. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
Jiang L; Chen J; He Y; Zhang Y; Li G
J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
[TBL] [Abstract][Full Text] [Related]
13. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
Crawford L; Rosch J; Putnam D
J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the Preparation Conditions of Borneol-Modified Ginkgolide Liposomes by Response Surface Methodology and Study of Their Blood Brain Barrier Permeability.
Lv Z; Yang Y; Wang J; Chen J; Li J; Di L
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385087
[TBL] [Abstract][Full Text] [Related]
15. The blood-brain barrier: clinical implications for drug delivery to the brain.
De Boer AG; Breimer DD
J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704
[TBL] [Abstract][Full Text] [Related]
16. Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D.
Morales JF; Montoto SS; Fagiolino P; Ruiz ME
Mini Rev Med Chem; 2017; 17(3):247-257. PubMed ID: 27739359
[TBL] [Abstract][Full Text] [Related]
17. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies.
Yi T; Tang D; Wang F; Zhang J; Zhang J; Wang J; Xu X; Zhang J
Drug Deliv; 2017 Nov; 24(1):422-429. PubMed ID: 28165806
[TBL] [Abstract][Full Text] [Related]
18. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
19. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
20. Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma.
Tan X; Zhang K; Shi W; Tang Z
Transl Cancer Res; 2023 Nov; 12(11):3198-3209. PubMed ID: 38130309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
